PCV17 PROJECTED IMPACT ON CORONARY HEART DISEASE OF ADDING PROLONGED-RELEASE NICOTINIC ACID (NIASPAN®) TO STATIN TREATMENT IN EUROPEAN PATIENTS WITH TYPE 2 DIABETES
Nov 1, 2006, 00:00 AM
10.1016/S1098-3015(10)63633-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)63633-9/fulltext
Section Title :
Section Order :
484
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)63633-9&doi=10.1016/S1098-3015(10)63633-9